Technical Analysis for NEO - NeoGenomics, Inc.

Grade Last Price % Change Price Change
grade B 18.76 -5.44% -1.08
NEO closed down 5.44 percent on Friday, March 22, 2019, on 49 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Down
See historical NEO trend table...

Date Alert Name Type % Chg
Mar 22 Fell Below 20 DMA Bearish 0.00%
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 21 Bollinger Band Squeeze Range Contraction -5.44%
Mar 21 Multiple of Ten Bearish Other -5.44%
Mar 21 BB Squeeze + Upper Band Touch Range Contraction -5.44%
Mar 21 Upper Bollinger Band Touch Strength -5.44%
Mar 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -3.50%
Mar 20 Bollinger Band Squeeze Range Contraction -3.50%
Mar 20 Down 3 Days in a Row Weakness -3.50%
Mar 19 Stochastic Sell Signal Bearish -4.38%

Older signals for NEO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company performs analyses for hematopoietic cancers, such as leukemia and lymphoma; and solid tumor cancers comprising breast, lung, colon, and bladder cancer. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry testing services to identify cell proteins in a tissue section; and molecular testing services that focus on the analysis of DNA and RNA, as well as on the structure and function of genes at the molecular level. The company's trademarks include NeoFISH, NeoFlow, NeoSITE, NeoArray, NeoType, and MelanoSITE. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Cancer Biology Diseases Genetics Lymphoma Medical Tests Leukemia Laboratory Techniques Anatomical Pathology Bladder Cancer Solid Tumor Cancers Hybridization Cytogenetics Fluorescence In Situ Hybridization
Is NEO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.31
52 Week Low 7.71
Average Volume 1,356,936
200-Day Moving Average 15.0492
50-Day Moving Average 17.6798
20-Day Moving Average 19.3005
10-Day Moving Average 19.516
Average True Range 0.6792
ADX 18.54
+DI 20.8713
-DI 21.4424
Chandelier Exit (Long, 3 ATRs ) 18.2724
Chandelier Exit (Short, 3 ATRs ) 20.0376
Upper Bollinger Band 20.1309
Lower Bollinger Band 18.4701
Percent B (%b) 0.17
BandWidth 8.604958
MACD Line 0.5266
MACD Signal Line 0.6637
MACD Histogram -0.1371
Fundamentals Value
Market Cap 1.49 Billion
Num Shares 79.4 Million
EPS -0.33
Price-to-Earnings (P/E) Ratio -56.85
Price-to-Sales 2.72
Price-to-Book 4.01
PEG Ratio 3.28
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.58
Resistance 3 (R3) 20.76 20.34 20.27
Resistance 2 (R2) 20.34 19.88 20.25 20.17
Resistance 1 (R1) 19.55 19.59 19.34 19.37 20.07
Pivot Point 19.13 19.13 19.03 19.04 19.13
Support 1 (S1) 18.34 18.67 18.13 18.16 17.45
Support 2 (S2) 17.92 18.38 17.83 17.35
Support 3 (S3) 17.13 17.92 17.25
Support 4 (S4) 16.95